Results 151 to 160 of about 6,042 (221)

Real-World Experience of Guselkumab in the Elderly Population. [PDF]

Psoriasis (Auckl)
Fratton Z, Bighetti S, Bettolini L, Maione V, Rossi M, Venturini M, Mazzoletti V, Zelin E, Stinco G, Errichetti E.   +9 more
europepmc   +1 more source

Interleukin 12/23 and interleukin 23 inhibitors for moderate-to-severe ulcerative colitis: a systematic review and network meta-analysis. [PDF]

Ann Gastroenterol
Sawaf B, Hayek MA, Kassem A, Alsoud D, Alom M, Salam AH, Shembesh RH, Beshr MS, Hallak Y, Abbarh S, Batikh E, Shibani M, Elhadi M, Alastal Y, Regueiro M.   +14 more
europepmc   +1 more source

Assessing T-Cell Profile Shifts through IL-23 Inhibition by Guselkumab on Psoriasis. [PDF]

JID Innov
Kanayama Y, Watanabe O, Sakurai M, Enomoto Y, Yamamoto A, Mashiko S, Sugiura Y, Miyashiro M, Masuda J, Morita A.   +9 more
europepmc   +1 more source

Long-Term Persistence with Guselkumab: A 5-Year Multicenter Retrospective Study across 14 Dermatology Centers in Italy. [PDF]

Dermatol Pract Concept
Nicoletta B, Giacomo C, Antonio Giovanni R, Maria E, Federica T, Paolo A, Edvige M, Claudio B, Dario G, Luigi BP, Domenico G, Severino P, Annamaria M, Gaia M, Gianluca P, Sabatino P, Jasmine A, Cristina M, Emanuele M, Vincenzo P, Elisa M, Oriana S, Concetta FM, Ketty P, Giovanni P, Concetta P, Annunziata D.   +26 more
europepmc   +1 more source

Case Report: Successful treatment of guselkumab in a patient with verrucous psoriasis unresponsive to secukinumab. [PDF]

Front Immunol
Zheng J, Yi X, Shi Y, Ding Y.
europepmc   +1 more source

Predictive Factors of Early Super-Response to Biologic Agents in Psoriasis: Insights from Real-World Evidence. [PDF]

Clin Cosmet Investig Dermatol
Koç Yıldırım S, Ayyıldız SM, Demirel Öğüt N, Erbağcı E, Ünal S, Gokyayla E.   +5 more
europepmc   +1 more source

Guselkumab In A Subset Of Multifailure Patients With Hidradenitis Suppurativa: Real-Word Evidence from Federico II. [PDF]

Clin Cosmet Investig Dermatol
Martora F, Tommasino N, Coronella L, Potestio L, Battista T, Megna M.   +5 more
europepmc   +1 more source

Diabetic ketoacidosis as the initial presentation of hepatogenous diabetes: a first reported case. [PDF]

Endocrinol Diabetes Metab Case Rep
Kutaiba Albuni M, Abbarh S, Ashraf Ibrahem Fathy Hassan N, Sawaf B, Ahmed AI, Hallak Y, Azzawi M.   +6 more
europepmc   +1 more source

Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA) [PDF]

Bianchi, Luca, Khemis, Abdallah, Maul, Julia-Tatjana, Noergaard, Mia M, Petersen, Kim, Puig, Lluis, Reich, Kristian, Schempp, Christoph M, Tsianakas, Athanasios   +8 more
core   +1 more source